Allurion Technologies Inc (ALUR)
0.3778
+0.03
(+10.15%)
USD |
NYSE |
Nov 18, 16:00
0.399
+0.02
(+5.61%)
After-Hours: 20:00
Allurion Technologies Shareholders Equity (Quarterly): -64.79M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -64.79M |
| June 30, 2024 | -70.58M |
| March 31, 2024 | -66.16M |
| December 31, 2023 | -70.49M |
| Date | Value |
|---|---|
| September 30, 2023 | -52.76M |
| June 30, 2023 | -110.34M |
| March 31, 2023 | -88.78M |
| December 31, 2022 | -32.31M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-110.34M
Minimum
Jun 2023
-32.31M
Maximum
Dec 2022
-69.53M
Average
-68.32M
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 328.47M |
| Retractable Technologies Inc | 83.46M |
| InfuSystems Holdings Inc | 55.51M |
| Xtant Medical Holdings Inc | 45.72M |
| Catheter Precision Inc | 12.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 50.70M |
| Total Liabilities (Quarterly) | 115.49M |
| Debt to Equity Ratio | -0.557 |
| Current Ratio | 2.330 |
| Net Debt Paydown Yield | 19.00% |